Search
SHENZHEN, CHINA — Durastab Medtech Co., Ltd. today announced expanded OEM and large-volume supply of its Durastab™ TMB ELISA substrates for in-vitro diagnostics (IVD) and kit manufacturers worldwide.
The company's ISO9001:2015-certified production supports single-batch volumes from 100 to 1950 liters, ensuring stable, consistent supply for customers scaling from development to commercial production.
OEM & Bulk Capabilities
Large-batch production up to 1950 L per batch with batch-to-batch consistency verified by direct ELISA.
Custom formulations — TMB activity and profile tailored to specific development needs.
Four kinetic options — High Sensitive, One Component (Standard), Board Range and Slow Plus.
Freeze-thaw resistant variants (suffix -F) for complex logistics.
Global reach — serving 600+ companies, thousands of research institutions and 50+ listed IVD companies.
Quality Control & Reproducibility
Durastab™ TMB substrates are produced under an ISO9001:2015 quality-management system. Batch-to-batch consistency is verified by direct ELISA across graded HRP concentrations, and a single production batch can scale up to 1950 L — giving IVD and kit manufacturers a stable, reproducible substrate for commercial manufacturing.
About Durastab Medtech
Durastab Medtech Co., Ltd. develops ready-to-use reagents for diagnostic platforms including ELISA, chemiluminescence, Western blot and microarrays, with a product line spanning chromogenic and luminescent substrates, enzyme/protein stabilizers, blockers, enhancers and IVD preservatives.
The company is based in Shenzhen, China. For enquiries, contact sales@durastab.com or call +86-0755-32813268.
